Alkermes to Report Second Quarter Financial Results on July 29, 2025,PR Newswire Healthring


Alkermes to Announce Second Quarter 2025 Financial Results on July 29th

Alkermes plc (NASDAQ: ALKS), a biopharmaceutical company committed to developing innovative medicines for diseases of the central nervous system (CNS) and oncology, has announced its plan to report its financial results for the second quarter of 2025. The company will release this information after the market closes on Tuesday, July 29, 2025.

Following the release of the financial results, Alkermes’ management team will host a conference call and live webcast to discuss the company’s performance and strategic priorities. The webcast will provide stakeholders with an opportunity to hear directly from the company’s leadership and gain insights into its ongoing progress and future outlook.

Details regarding the timing of the conference call, including dial-in information and the webcast link, will be made available closer to the announcement date. Investors and interested parties are encouraged to monitor Alkermes’ investor relations website for these updates. This upcoming announcement is a key event for the financial community as it will offer a comprehensive overview of the company’s financial health and operational achievements during the second quarter of 2025.


Alkermes to Report Second Quarter Financial Results on July 29, 2025


AI has delivered the news.

The answer to the following question is obtained from Google Gemini.


PR Newswire Healthring published ‘Alkermes to Report Second Quarter Financial Results on July 29, 2025’ at 2025-07-15 20:00. Please write a detailed article about this news in a polite tone with relevant information. Please reply in English with the article only.

Leave a Comment